Join
Live feed
·
INSIDERFilingvia Quantisnow
Addex Therapeutics Ltd logo

CHIEF EXECUTIVE OFFICER Dyer Timothy Mark returned 16,413,787 shares to the company and was granted 16,413,787 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADXN (Addex Therapeutics Ltd) and more on Quantisnow.